We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$164B
AUM Growth
+$11.8B
Cap. Flow
+$2.23B
Cap. Flow %
1.36%
Top 10 Hldgs %
25.88%
Holding
4,146
New
203
Increased
1,918
Reduced
1,677
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 16.27%
2 Financials 8.92%
3 Healthcare 7.98%
4 Industrials 6.57%
5 Consumer Discretionary 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBK icon
376
Vanguard Small-Cap Growth ETF
VBK
$23.2B
$64.6M 0.04%
241,795
-3,817
-2% -$978K
EMN icon
377
Eastman Chemical
EMN
$7.79B
$64.1M 0.04%
572,808
+36,365
+7% +$3.64M
ROL icon
378
Rollins
ROL
$18.8B
$64.1M 0.04%
1,266,989
+30,568
+2% +$1.51M
GIS icon
379
General Mills
GIS
$20.1B
$64M 0.04%
866,977
-70,193
-7% -$4.86M
PPL
380
PPL Corp
PPL
$27.3B
$63.8M 0.04%
1,928,046
+413,517
+27% +$12.7M
MCHP icon
381
Microchip Technology
MCHP
$41.1B
$63.8M 0.04%
794,008
-75,025
-9% -$6.19M
FBND icon
382
Fidelity Total Bond ETF
FBND
$27.2B
$63.4M 0.04%
1,357,174
+168,180
+14% +$7.77M
MLN icon
383
VanEck Long Muni ETF
MLN
$682M
$62.7M 0.04%
3,427,963
+1,232,833
+56% +$22.3M
EFV icon
384
iShares MSCI EAFE Value ETF
EFV
$28.4B
$62.6M 0.04%
1,088,105
+226,276
+26% +$12.5M
VMC icon
385
Vulcan Materials
VMC
$37.4B
$62.3M 0.04%
248,884
+46,345
+23% +$11.5M
HIG icon
386
Hartford Financial Services
HIG
$39.3B
$62.3M 0.04%
529,504
-53,040
-9% -$5.81M
EME icon
387
Emcor
EME
$31.4B
$62.2M 0.04%
144,469
-171
-0.1% -$64.5K
CSX icon
388
CSX Corp
CSX
$94.2B
$62.1M 0.04%
1,799,424
+3,539
+0.2% +$120K
VRT icon
389
Vertiv
VRT
$104B
$62.1M 0.04%
624,173
+81,434
+15% +$6.75M
LRCX icon
390
Lam Research
LRCX
$337B
$61.5M 0.04%
753,210
-60,130
-7% -$5.23M
PDP icon
391
Invesco Dorsey Wright Momentum ETF
PDP
$1.42B
$61.5M 0.04%
595,138
+7,932
+1% +$783K
BCE icon
392
BCE
BCE
$20.3B
$61.4M 0.04%
1,764,263
-46,830
-3% -$1.6M
GM icon
393
General Motors
GM
$81.7B
$61.4M 0.04%
1,368,362
-2,816
-0.2% -$131K
WELL icon
394
Welltower
WELL
$175B
$61.2M 0.04%
478,207
+42,018
+10% +$4.9M
PHM icon
395
Pultegroup
PHM
$25.7B
$60.1M 0.04%
418,737
+92,879
+29% +$11.8M
NVS icon
396
Novartis
NVS
$304B
$59.6M 0.04%
518,181
-18,426
-3% -$2.09M
COR icon
397
Cencora
COR
$62.2B
$59.6M 0.04%
264,649
-2,475
-0.9% -$575K
SPYG icon
398
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$50.4B
$59.4M 0.04%
716,405
+9,850
+1% +$787K
DOW icon
399
Dow Inc
DOW
$20.8B
$59.1M 0.04%
1,081,513
+16,901
+2% +$892K
MMM icon
400
3M
MMM
$94.1B
$58.5M 0.04%
428,160
-245,128
-36% -$30M

Similar funds

Raymond James & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Raymond James & Associates held 4,146 positions worth $164B, up 7.7% from $152B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Raymond James & Associates's Q3 2024 filing shows 203 new, 1,918 increased, 1,677 reduced and 157 closed positions. Its largest new stake was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $516M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2024 buy was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M.
  • Raymond James & Associates added most to iShares Core S&P Mid-Cap ETF in Q3 2024, an estimated $520M increase.
  • Raymond James & Associates's biggest Q3 2024 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $516M.
  • Raymond James & Associates fully exited Ferguson in Q3 2024, selling an estimated $63.3M.
  • Raymond James & Associates's ten largest holdings make up 26% of its $164B portfolio in Q3 2024.
  • Raymond James & Associates opened 203 new positions and closed 157 in Q3 2024.
  • Raymond James & Associates's portfolio value rose 7.7% quarter-over-quarter to $164B.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.